635.59998 EUR
10.6
1.64%
Last update Dec 16, 9:19 AM CET
Main market
Day range
635.59998
635.59998
Previous close
646.20001
Open
635.59998
Access this stock data via API
Subscribe
Regeneron Pharmaceuticals, Inc.
635.60
10.60
1.64%

Financials

Income statement

Fundamentals currency is USD
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 3.2B 3.1B 2.6B 3.2B
Cost of revenue 444.5M 451.9M 395.7M 481.9M
Gross profit 2.8B 2.7B 2.2B 2.7B
Operating expense
Research & development 1.3B 1.2B 1.1B 1.2B
Selling general and admin 560.6M 540.5M 539.5M 675.2M
Other operating expenses -8.5M 13.2M
Operating income 945.9M 920.0M 504.3M 843.9M
Non operating interest income
Income 149.2M 149.0M 147.9M 156.0M
Expense 16.4M 3.1M 7.4M 8.9M
Other income expense 424.1M 228.4M 126.6M -174.5M
Pretax income 1.5B 1.3B 771.3M 816.5M
Tax provision 258.5M 108.3M 82.1M 34.4M
Net income 1.2B 1.2B 689.2M 782.1M
Basic EPS 13.2 7.6 8.5
Diluted EPS 12.8 7.3 8.1
Basic average shares 89.6M 90.9M 91.7M
Diluted average shares 92.6M 94.8M 97.0M
EBITDA 1.2B 1.2B 767.8M 1.1B
Net income from continuing op. 1.2B 1.2B 689.2M 782.1M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 9 hours 44 minutes

12:15
00:00
08:00
22:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 22:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).